| 引用本文: | 侯凯,费禹翔,杨宇,张金莲,王芳,李平.一例遗传性易栓症患儿脑静脉窦血栓抗凝治疗的药学实践及文献阅读[J].中国现代应用药学,2025,42(2):69-74. |
| HOUKAI,Fei Yuxiang,Yang Yu,Zhang Jinlian,Wang Fanf,Li Ping.Pharmaceutical Practice of Anticoagulant Therapy for Cerebral Venous Sinus Thrombosis in Pediatric Patient with Hereditary Thrombophilia and literature review[J].Chin J Mod Appl Pharm(中国现代应用药学),2025,42(2):69-74. |
|
| 摘要: |
| 颅内静脉和静脉窦血栓约占所有脑卒中的0.5%-1.0%，在儿科患者中则更为罕见。遗传性易栓症是脑静脉窦血栓形成的潜在病因。目的 探讨临床药师在儿童脑静脉窦血栓的抗凝药物治疗中的作用。方法 临床药师参与1例遗传性易栓症患儿脑静脉窦血栓栓塞的抗栓治疗管理，通过查阅相关指南和文献分析抗栓药物的特点，结合患儿临床表现、凝血功能和抗Xa水平等多次会诊参与制定和优化患儿脑静脉窦血栓溶栓方案以及易栓症的抗凝方案，为患儿提供安全、有效、个体化的药学监护。结果 患儿的静脉血栓栓塞得到良好控制并好转出院，且治疗过程未发生出血等不良反应。结论 临床药师通过药学会诊为患儿提供个体化用药监护，有效提高抗凝药物治疗效果，降低出血风险，为易栓症患儿脑静脉窦血栓的防治提供参考。 |
| 关键词: 儿科患者 遗传性易栓症 脑静脉窦血栓 抗凝治疗 临床药师 |
| DOI： |
| 分类号: |
| 基金项目:国家自然科学基金-青年科学基金项目(NO.82204394)；南京药学会常州四药医院药学科研基金项目(No.2022YX003) |
|
| Pharmaceutical Practice of Anticoagulant Therapy for Cerebral Venous Sinus Thrombosis in Pediatric Patient with Hereditary Thrombophilia and literature review |
|
HOUKAI1, Fei Yuxiang2, Yang Yu3, Zhang Jinlian3, Wang Fanf3, Li Ping3
|
|
1.Department of Pharmacy, Zhongda Hospital, Southeast University;2.Department of Pharmacy, Nanjing First Hospital, Nanjing Medical University;3.Department of Clinical Pharmacy, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University
|
| Abstract: |
| Cerebral venous and sinus thrombosis accounts for about 0.5%-1.0% of all strokes and is even rarer in pediatric patients. Genetic thrombophilia is a potential cause of cerebral venous sinus thrombosis. OBJECTIVE To explore the role of clinical pharmacists in the anticoagulant treatment of cerebral venous sinus thrombosis in pediatric patients. METHODS Clinical pharmacist participated in the management of antithrombotic therapy for a case of cerebral venous sinus thrombosis in a pediatric patient with hereditary thrombophilia. Through reviewing relevant guidelines and research analysis, combined with the clinical manifestations, coagulation function and anti-Xa level of the pediatric patient, clinical pharmacist participated in the formulation and optimization of thrombolysis scheme for cerebral venous sinus thrombosis in children and anticoagulation scheme for thrombophilia, so as to provide safe, effective and individualized pharmaceutical care for children. RESULTS The venous thromboembolism of the children had been controlled in time and discharged from hospital, and no adverse reactions such as bleeding occurred during the treatment. CONCLUSION Clinical pharmacists provide individualized medication monitoring for pediatric patients through pharmaceutical consultations, effectively improving the effectiveness of anticoagulant therapy, reducing the risk of bleeding, and providing reference for the prevention and treatment of cerebral venous sinus thrombosis in children with thrombophilia. |
| Key words: pediatric patient hereditary thrombophilia cerebral venous sinus thrombosis anticoagulation therapy clinical pharmacist |
